Key result
Heart failure is linked to ~33% higher incidence of incident cancer.
Why the study?
Cancer and heart failure frequently coexist, and a potential association between heart failure and subsequent cancer incidence has been recently noticed but not quantified.
Does heart failure increase the incidence of cancer and mortality in adult populations?
Meta-Analysis (n=8,979,195)
Does heart failure increase the incidence of cancer and mortality in adult populations?
Hazard Ratio: 1.33 (95% CI 1.14–1.54)
Heart failure is associated with a 33% relative increase in the incidence of cancer, particularly lung, colorectal, and breast cancers, though the relationship is confounded by marked study heterogeneity and shared risk factors.
May inform cancer surveillance in heart failure; leaves open causality given observational design and high heterogeneity.
BACKGROUND: Cancer and heart failure (HF) frequently coexist due to population ageing and improved survival for both conditions. HF is a well-recognised complication of oncologic therapies and a potential association between HF and subsequent cancer incidence has been recently noticed. We therefore conducted a meta-analysis to quantify cancer incidence and mortality in patients with and without HF. METHODS: Databases were searched from inception to 15 February 2026. Data from observational studies and randomised trials on individuals with and without HF and reporting cancer incidence and/or mortality during follow-up were included. The main outcome of interest was the incidence of any cancer; secondary outcomes included site-specific cancer incidence (lung, colorectal, breast, and prostate) and all-cause, cardiovascular, and cancer-related mortality. RESULTS: Twelve studies comprising 8,979,195 individuals were included. HF was associated with a higher incidence of cancer (hazard ratio [HR] 1.33, 95% confidence interval [CI] 1.14-1.54), with substantial heterogeneity (I2 = 99.7%). Cancer site-specific analyses showed increased incidences of lung (HR 1.70, 95% CI 1.26-2.29), colorectal (HR 1.28, 95% CI 1.11-1.48), and breast (HR 1.19, 95% CI 1.04-1.37), but not prostate, cancer. Effect estimates varied according to analytical strategy: matched HF and non-HF cohorts reported higher risk estimates than those using covariate adjustment without matching. Mortality data were sparse and heterogeneous. CONCLUSIONS: HF is associated with a higher incidence of cancer, although with marked heterogeneity among studies and cancer types. Mortality and cause of death were rarely reported. The observed HF-cancer association is influenced by statistical methodology, shared risk factors, differences in surveillance intensity and cancer type, that confound analyses investigating possible causal biological links. More granular and harmonised studies are required.
No takes yet. Share an insight, caveat, or question.
Iaconelli et al. (2026) conducted a meta-analysis in Heart Failure (n=8,979,195). Heart failure vs. No heart failure was evaluated on Incidence of any cancer (HR 1.33, 95% CI 1.14-1.54). Heart failure is associated with a 33% higher incidence of subsequent cancer compared to individuals without heart failure (HR 1.33).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: